The 20 Best Brain Tumor Doctors Near Me in Ann Arbor, MI

Dr. Wahl is a physician scientist at the University of Michigan specializing in cancers of the central nervous system. His research focuses on the development of new treatment strategies for brain tumors and his laboratory group is especially interested in interactions between radiation and abnormal metabolism in glioblastoma. In the clinic, he cares for a wide variety of patients with both malignant and benign tumors of the central nervous system. Dr. Wahl is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Dr. Jason Heth attended The University of Iowa where he received his medical degree and also completed his residency in Neurosurgery. Dr. Heth then completed additional training in Skull Base Neurosurgery, completing a fellowship at the University of Arkansas for Medical Sciences. After completing his fellowship, he joined the faculty of the University of Michigan. Dr. Heth specializes in brain tumor treatment, including surgical removal, radiosurgery, and basic research. His primary areas of interest focus on gliomas, glioblastoma, brain metastasis, and meningiomas. He is also involved in medical student education and quality improvement programs at the University of Michigan. Dr. Heth is rated as an Elite provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Brain Tumor, Awake Craniotomy, and Gastrostomy. Dr. Heth is board certified in Neurological Surgery.

Dr. Patricia Robertson, M.D., earned a medical degree at Wayne State University Medical School in Detroit and completed a residency in pediatrics at Children's Hospital of Michigan. She then went on to a fellowship in pediatric neurology at the University of Michigan and trained in pediatric neuro-oncology at New York University Medical Center. Dr. Robertson joined the University of Michigan faculty in 1988. She has a special interest in clinical pediatric neuro-oncology focusing on the evaluation of response, outcome and late effects on the developing nervous system; current treatment strategies for children with central nervous malignancies; and in the development of innovative treatment approaches for this population. Dr. Robertson is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Glioma, Diencephalic Syndrome, Brain Stem Cancer, and Brain Tumor.

Hugh Garton is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Garton is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Chiari Malformation, Chiari Malformation Type 1, Chiari Malformation Type 2, Posterior Fossa Decompression, and Gamma Knife Radiosurgery. Dr. Garton is board certified in Neurological Surgery.

Dr. Leung is the Director of the Neuro-Oncology Fellowship Program and is a clinical assistant professor in the Department of Neurology. She sees patients in the Neuro-Oncology Clinic at the Rogel Cancer Center and at the Northville Health Center. She completed a bachelor’s degree at the University of Western Ontario, a master’s degree at the University of Toronto, and medical degree at SUNY Upstate. Dr. Leung completed her Neurology residency and Neuro-Oncology fellowship at Henry Ford Hospital. Dr. Leung is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Metastatic Brain Tumor. Dr. Leung is board certified in Neurology.

Dr. Lawrence structured his career to prepare to be a physician scientist by obtaining both an MD and PhD. He initially pursued internal medicine and medical oncology, but ultimately settled on radiation oncology. He is board certified in all 3 areas. He has had an active clinical practice in radiation oncology for 30 years specializing in the treatment of patients with gastrointestinal malignancies and CNS tumors.Dr. Lawrence has focused his research career in two main areas. First, in collaboration with basic scientists he developed a laboratory program in chemotherapeutic radiation sensitizers and, more recently, has studied how to integrate molecularly targeted therapies. He collaborates with basic science faculty interested in translational research to investigate new combinations that can form the basis for rational clinical trials. The second area of focus involves the use of highly conformal radiation therapy in the treatment of brain and gastrointestinal cancers. In particular, he is focusing, in collaboration with medical physicists, radiologists, imaging scientists, and biologists, on the concept of adapting treatment to the individual patient response, assessed both by state-of-the-art imaging and plasma biomarkers.Dr. Lawrence is the author of over 300 peer-reviewed publications, and his work has been continuously supported by the National Cancer Institute for over 20 years. Dr. Lawrence is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Astrocytoma, Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Lawrence is board certified in Radiation Oncology, Medical Oncology, and Internal Medicine.

Michael Karsy, MD, PhD, MSc, FAANS is a Clinical Assistant Professor of Neurosurgery at the University of Michigan. He completed his undergraduate degree with honors in Neuroscience at the University of California Los Angeles and a combined MD/PhD program at New York Medical College. He then completed residency in neurosurgery at the University of Utah under Dr. William Couldwell in 2020 with enfolded fellowship in Complex Spine Surgery with Dr. Andrew Dailey and Dr. Erica Bisson as well as a Masters of Bioengineering in Medical Device Development. And he completed a Skull Base fellowship at Thomas Jefferson University Hospital under Dr. James Evans in 2021.He practices at both the University of Michigan Health – Sparrow and University of Michigan Health – Ann Arbor. His primary focus is on neuro-oncology and skull base pathologies with specialization in endoscopic and minimally invasive approaches. He works as part of a large multi-disciplinary team managing neuro-oncology issues (e.g., pituitary adenomas, meningiomas, gliomas, vestibular schwannomas, metastatic disease). He also has an interest in spine management (e.g., minimally invasive spine surgery, cervical myelopathy, spine tumors, trauma, deformity). Dr. Karsy also currently serves as the Director of Clinical Operations and Quality at University of Michigan Health – Sparrow and previously served as faculty at the University of Utah and Drexel University College of Medicine.His research interests are in molecular characterization and targeted therapy of skull base pathologies, multi-institutional collaboration to advance skull base research, improving healthcare outcomes, and reducing surgical complications through improved integration of techniques and technology in neurosurgery. He has >200 publications, a dozen book chapters, and a surgical textbook. He has participated as a co-investigator and principal investigator on multiple clinical trials in neurosurgical trauma, critical care, and neuro-oncology. Dr. Karsy enjoys working with medical students, residents, and fellows both locally and nationally in a variety of research endeavors. He is currently active in the North American Skull Base Society among areas of organized neurosurgery.Dr. Karsy is Board Certified by the American Board of Neurological Surgery. He also speaks Persian and Spanish. In his spare time, he enjoys reading, movies, mountain biking, hiking, and spending time with his wife and two children. Dr. Karsy is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Hypothalamic Tumor, Pituitary Tumor, Meningioma, Endoscopic Transnasal Transsphenoidal Surgery, and Thrombectomy.

Todd Hollon is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Hollon is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Prolactinoma, Brain Tumor, Awake Craniotomy, and Septoplasty.

Dr. Wajd Al-Holou was raised in southeast Michigan. After attending the University of Michigan Medical School, where he graduated with the highest award for research, he then began a 7-year Neurosurgery residency at the University of Michigan. Upon completion of residency in 2016, he completed a Complex Neurosurgical Oncology Fellowship at the MD Anderson Cancer Center in Houston, TX. His training focused on the management of complex brain tumors, spinal tumors, and skull base malignancies.Dr. Al-Holou specializes in the management of complex brain tumors, primarily focusing on gliomas and metastases to the brain. Dr. Al-Holou has expertise in the use of awake mapping techniques, microsurgery, and image-guidance to maximize tumor removal in the safest possible manner. He also specializes in the management of meningiomas and spinal tumors.Dr. Al-Holou is the co-founder and co-director of the Michigan Medicine Multidisciplinary Brain Tumor Clinic (M3BTC). As a member of this Neuro-Oncology multidisciplinary team, he works strategically to ensure personalized treatment recommendations that will maximize the benefits for each individual patient.Currently, he is a member of the AANS/CNS Executive Committee of the Section on Tumors. He served as the Co-Chair for Tumor Section Scientific Program for the American Association of Neurological Surgeons (AANS) in 2018 and is a member of the Society of Neuro-Oncology. He also serves as an editor for cancer journal, BMC Cancer.Dr. Al-Holou is committed to research and education in Neurosurgery and his life-long goal is improving the survival and outcomes for patients with tumors. His research interest focuses primarily on understanding the genetic mechanisms of recurrence in glioblastoma, and in identifying precision medicine therapies to target resistant tumors. Dr. Al is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Astrocytoma, Oligodendroglioma, and Awake Craniotomy. Dr. Al is board certified in Neurological Surgery.

After completing his chief residency at the University of Virginia, Dr. Sagher accepted a position on the neurosurgical faculty at the University of Michigan. He became Chief of Neurosurgery at the Ann Arbor Veterans Administration Hospital, a position he held until 1996. He then completed a fellowship in Pain and Functional Neurosurgery at the Oregon Health Sciences University, and took over as the Director of Neuromodulation at the University of Michigan. As the primary functional neurosurgeon at the University of Michigan, Dr. Sagher takes care of such problems as epilepsy, pain, Parkinson's Disease and other movement disorders. Dr. Sagher is board certified by the American Board of Neurological Surgeons, and is a member of the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS). He has served on the Executive Council on the AANS/CNS Joint Section on Pain, which he chaired from 2003 to 2005. Special Interests: The treatment of epilepsy, pain, movement disorders, and brain tumors in functionally important regions. Dr. Sagher is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Trigeminal Neuralgia, Meningioma, Seizures, Awake Craniotomy, and Microvascular Decompression. Dr. Sagher is board certified in Neurological Surgery.

Nathan Clarke is a Neurologist practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Clarke is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Brain Tumor, and Glioblastoma. Dr. Clarke is board certified in Neurology.

Larry Junck is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Junck is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor.

Dr. Mihaylova was born and raised in Bulgaria where she completed Medical School at the University of Sofia in 1997. Subsequently she extended her training into a three-year post-doctoral program and conducted clinical research on newly diagnosed epilepsy patients. She was granted her PhD degree in 2002. Since then she has been living in the US where she completed her Neurology residency at Wayne State University followed by a year of fellowship training in Clinical Neurophysiology with emphasis on Epilepsy/EEG at the same institution. Her primary clinical and research interests involve the treatment of medically intractable epilepsy including VNS and surgical treatment, EEG analysis and seizure semiology. Dr. Mihaylova is rated as an Experienced provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Seizures, Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE), Generalized Tonic-Clonic Seizure, and Partial Seizure. Dr. Mihaylova is board certified in Neurology, Clinical Neurophysiology, and Epilepsy.

Dr. Derek Bergsma is active in clinical practice at the Lacks Cancer Center Department of Radiation Oncology in Grand Rapids. He received his undergraduate degree from Grand Valley State University and then worked in cancer immunodiagnostics at Van Andel Institute before obtaining his medical degree from Michigan State University College of Human Medicine. He completed both internship and Radiation Oncology residency at the University of Rochester in Rochester, NY. Dr. Bergsma is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Brain Tumor, Astrocytoma, and Oligodendroglioma. Dr. Bergsma is board certified in Radiation Oncology.

Karin Muraszko, M.D., grew up in New Jersey and received her undergraduate degree from Yale University. She then continued to Columbia University in New York where she received her medical degree and completed her residency training in Neurological Surgery and completed fellowships in pediatric neurosurgery.Following her training at Columbia, Dr. Muraszko was a researcher at the National Institutes for Health for two years before joining the team at the University of Michigan. From 2005 to 2022, Dr. Muraszko served as the head the Department of Neurosurgery at the University of Michigan. She was the first woman to chair an academic neurosurgery department in the United States.Dr. Muraszko specializes in pediatric neurosurgery. She is board certified by the American Board of Neurological Surgeons, and is a member of the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS) along with several pediatric professional associations. Her research interests include Immunotoxin therapy for brain tumors, the biology of brain tumors, Chiari malformations, craniofacial anomalies, congenital anomalies of the brain and spine and hydrocephalus.Dr. Muraszko lives in Ann Arbor with her husband and two children. Dr. Muraszko is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Chiari Malformation, Chiari Malformation Type 2, Tethered Cord Syndrome, Posterior Fossa Decompression, and Bone Graft. Dr. Muraszko is board certified in Neurological Surgery and Pediatric Neurosurgery.

Dr. Magge is a Clinical Professor of Neurosurgery and serves as the Surgical Director of the Pediatric Brain Tumor Program. His clinical practice encompasses all types of pediatric neurosurgery, with particular clinical and research interests in pediatric brain tumors, craniosynostosis (endoscopic and open surgery), and pediatric neurovascular disease (including AVM’s and moyamoya disease). His brain tumor research has focused on finding better treatments for diffuse intrinsic pontine gliomas (DIPG’s) and methods for liquid biopsy. He has been involved in multicenter clinical trials. In the field of craniosynostosis, he has been the principal investigator of a multicenter trial examining long term outcomes of children with craniosynostosis treated with either endoscopic or open surgery. He also started the first endoscopic craniosynostosis surgery program in the Washington, DC area and helped to grow a busy craniosynostosis practice in California. He has authored numerous scholarly papers, and he is a regular speaker at national and international conferences. Dr. Magge works to find the best treatment for each patient in the least invasive method possible.Prior to joining University of Michigan Health, Dr. Magge served as the Director of Neurosurgery and Co-Director of the Children’s Hospital of Orange County Neuroscience Institute and Professor of Clinical Neurosurgery at University of California Irvine. Prior to that, he was a faculty member in the Division of Pediatric Neurosurgery at Children’s National Hospital in Washington, DC, where he started the pediatric neurosurgery fellowship program and served as fellowship director.Dr. Magge grew up in Cincinnati, Ohio, and he attended Harvard College for his undergraduate studies, where he majored in biochemistry. He then obtained his medical degree from Harvard Medical School, graduating in 2001. During medical school, he completed a 1 year Howard Hughes research fellowship at the NIH. He then completed neurosurgery residency training at the University of Pennsylvania in 2008, and fellowship training in pediatric neurosurgery at Boston Children’s Hospital in 2009. Dr. Magge is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Craniosynostosis, Plagiocephaly, Cortical Dysplasia, Craniectomy, and Posterior Fossa Decompression. Dr. Magge is board certified in Neurological Surgery and Pediatric Neurosurgery.

Neena Marupudi is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Marupudi is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 53 other conditions, according to our data. Her clinical expertise encompasses Hydrocephalus, Tethered Cord Syndrome, Chiari Malformation Type 1, Rhizotomy, and Laminectomy. Dr. Marupudi is board certified in Neurological Surgery.

Michelle Kim, M.D. is an associate professor in the Department of Radiation Oncology at the University of Michigan. She completed her medical training at Case Western Reserve University and her residency at MD Anderson Cancer Center. Dr. Kim is board-certified in Radiation Oncology by the American Board of Radiology. Her research focus is in the adaptive individualization of radiation therapy using advanced molecular and functional imaging for patients with central nervous system tumors including gliomas and brain metastases. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, and Astrocytoma. Dr. Kim is board certified in Radiation Oncology.

Dr. Morikawa joined the faculty in August 2014. After earning her M.Mus. in Piano Performance and M.PH in Epidemiology and Biostatistics from Boston University, Dr. Morikawa received her MD/Ph.D. at the Emory University School of Medicine. After completing her internal medicine residency training at Emory, she underwent fellowship training in Medical Oncology at Memorial Sloan Kettering Cancer Center. In 2014, she joined the faculty of the University of Michigan. She specializes in the care of patients with breast cancer at the Rogel Cancer Center. Her research involves clinical and translational investigations in breast cancer as well as brain and leptomeningeal metastases from solid tumors. Dr. Morikawa is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Morikawa is board certified in Internal Medicine and Medical Oncology.

David Altshuler is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Altshuler is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Rathke Cleft Cyst, Craniopharyngioma, Awake Craniotomy, and Extracranial-Intracranial Bypass Surgery.